HydroGenetics' Buffalo Biodiesel, Inc. Completes Capacity Expansion
April 24 2009 - 5:00PM
Marketwired
HydroGenetics, Inc. (PINKSHEETS: HYGN) is pleased to announce today
that Buffalo Biodiesel, a wholly owned subsidiary of HydroGenetics,
Inc., has completed the expansion of its processing facilities
increasing its capacity from 1 to 5 million gallons of biodiesel
annually. This represents a 500% total increase in production
capacity. HydroGenetics anticipates the already solid demand for
biodiesel will increase even more through federal mandates for its
use in government vehicles as well as consumer transportation.
Charles Hansen, CEO of HydroGenetics, Inc., stated: "The added
capacity has allowed us to enter into several contract negotiations
that I look forward to informing our stakeholders about in the near
future. Simply put, we are looking at this increased capacity as a
necessary step to fulfill demand." Currently a gallon of biodiesel
averages $2.20.
About HydroGenetics, Inc.
HydroGenetics, Inc. is an alternative energy company. The
company's mission is to acquire and develop alternative and "green"
technology companies into revenue producing, profitable businesses,
utilizing investment capital and other resources including
management and strategic planning to increase shareholder value.
HydroGenetics, Inc.'s wholly owned subsidiary, HydroAxis
Technologies, Inc., is currently developing "green hydrogen
generating technology systems for any internal combustion engine,"
which will significantly reduce gasoline consumption in existing
and new vehicles.
Forward-Looking Statements
Statements in this press release relating to plans, strategies,
economic performance and trends, projections of results of specific
activities or investments, and other statements that are not
descriptions of historical facts may be forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995, Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934. Forward-looking information
is inherently subject to risks and uncertainties, and actual
results could differ materially from those currently anticipated
due to a number of factors, which include but are not limited to,
risk factors inherent in doing business. Forward-looking statements
may be identified by terms such as "may," "will," "should,"
"could," "expects," "plans," "intends," "anticipates," "believes,"
"estimates," "predicts," "forecasts," "potential," or "continue,"
or similar terms or the negative of these terms. Although we
believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee future results,
levels of activity, performance or achievements. The company has no
obligation to update these forward-looking statements.
Contact: Mark Balbirer 305-573-0821
Hydrogenetics (CE) (USOTC:HYGN)
Historical Stock Chart
From Nov 2024 to Dec 2024
Hydrogenetics (CE) (USOTC:HYGN)
Historical Stock Chart
From Dec 2023 to Dec 2024